Velentium vs Cambridge Consultants: full comparison for 2026
Quick verdict
Velentium (4.5/5) edges ahead of Cambridge Consultants (4.4/5) overall. Velentium is the better choice for implantables and FDA cybersecurity submissions. Cambridge Consultants is the stronger option for novel technology with high technical risk. The right choice depends on your project size, budget, and required tech stack.
Velentium vs Cambridge Consultants: head-to-head summary
| Criterion | Velentium | Cambridge Consultants |
|---|---|---|
| Founded | 2012 | 1960 |
| HQ | Katy, TX, USA | Cambridge, UK (part of Capgemini) |
| Team size | 51–250 | 900+ |
| Rating | 4.5 / 5 | 4.4 / 5 |
| Primary differentiator | Combines active-implantable engineering with a dedicated device cybersecurity team that prepares FDA premarket security documentation | Physicists, chemists and engineers working in one building on problems no off-the-shelf design can solve |
| Pricing model | Fixed project, time and materials, manufacturing contract | Time and materials, phased fixed project |
| Min. engagement | Not disclosed | Not disclosed |
| Primary tech stack | Embedded C/C++, RTOS, BLE | Optics & photonics, RF, Embedded C/C++ |
| Industries served | Implantables & neuromodulation, Surgical & therapeutic devices, Wearables & remote monitoring | Diagnostics & lab devices, Surgical & robotics, Drug delivery, Digital health |
Velentium vs Cambridge Consultants: overview
Velentium
Velentium was founded in 2012 and is based in Katy, near Houston, Texas. It designs, develops and manufactures active medical devices, including implantables and their programmers, and offers systems engineering, firmware, software, cybersecurity and CGMP manufacturing. Great Point Partners completed a growth recapitalization in 2021, the company sold its oil and gas division in 2023 to focus fully on medtech, and it took $15M in growth financing from Trinity Capital in 2024. Headcount estimates range from 51 to 250.
Cambridge Consultants
Cambridge Consultants has done contract research and product development from Cambridge, UK, since 1960. It became part of Capgemini through the 2020 acquisition of Altran and now sits within Capgemini Invent, with a headcount of about 900 to 1,000. Medical and life sciences is one of its main sectors, and its public work includes the optics behind Ellume's FDA-authorized COVID-19 home test. Projects tend to involve new sensing, surgical robotics, drug delivery or diagnostics technology rather than incremental redesigns.
Services and capabilities: Velentium vs Cambridge Consultants
| Capability | Velentium | Cambridge Consultants |
|---|---|---|
| Electronics & PCB design | ✓ | ✓ |
| Firmware & embedded software | ✓ | ✓ |
| SaMD & companion apps | ✗ | ✗ |
| Connected devices & IoT | ✗ | ✗ |
| Industrial design & human factors | ✗ | ✓ |
| Mechanical engineering | ✗ | ✓ |
| Device cybersecurity | ✓ | ✗ |
| Regulatory & QMS support | ✓ | ✓ |
| Manufacturing & scale-up | ✓ | ✗ |
Tech stack comparison: Velentium vs Cambridge Consultants
| Framework / platform | Velentium | Cambridge Consultants |
|---|---|---|
| Embedded C/C++ | ✓ | ✓ |
| Embedded Linux | N/A | N/A |
| RTOS | ✓ | N/A |
| BLE | ✓ | N/A |
| Cloud (AWS/Azure) | N/A | N/A |
| IEC 62304 | ✓ | N/A |
| ISO 14971 | ✓ | N/A |
| ISO 13485 QMS | N/A | ✓ |
| Qt | N/A | N/A |
Pricing comparison: Velentium vs Cambridge Consultants
| Criterion | Velentium | Cambridge Consultants |
|---|---|---|
| Minimum engagement | Not disclosed | Not disclosed |
| Engagement models | Fixed project, Manufacturing contract, Time & materials | Consulting, Fixed project, Time & materials |
| Rate transparency | Not public | Not public |
| Price tier | Mid-market | Mid-market |
Target audience comparison: Velentium vs Cambridge Consultants
| Dimension | Velentium | Cambridge Consultants |
|---|---|---|
| Best company size | Startup to mid-market | Startup to mid-market |
| Best industries | Implantables & neuromodulation, Surgical & therapeutic devices, Wearables & remote monitoring | Diagnostics & lab devices, Surgical & robotics, Drug delivery |
| Best use cases | Building a neurostimulator and its clinician programmer, Preparing the cybersecurity section of an FDA 510(k) or PMA | Feasibility of a new sensing method for a point-of-care diagnostic, Early-stage surgical robotics architecture |
| Typical project type | Fixed project | Consulting |
Velentium vs Cambridge Consultants: pros and cons
| Velentium | |
|---|---|
| + | Cybersecurity is a full practice here, covering threat modeling, SBOMs, testing and postmarket monitoring |
| + | Experience with active implantable devices, one of the hardest device categories to engineer and certify |
| + | Can manufacture Class II and III devices after development, reducing transfer risk |
| + | Offers training on device cybersecurity, which helps client teams keep up after hand-off |
| - | Private-equity recapitalization and debt financing mean ownership priorities may shift over time |
| - | Smaller than the large consultancies, so very broad programs may stretch the team |
| - | Industrial design and human factors are not its main strength |
| Cambridge Consultants | |
|---|---|
| + | Rare breadth of science and engineering disciplines for early, risky technology work |
| + | Public medtech credits such as the Ellume home-test optics |
| + | Backing of Capgemini gives access to digital and manufacturing partners for later phases |
| + | Strong at feasibility studies that tell you whether an idea can work before you fund a full program |
| - | Owned by Capgemini since 2020, so pricing and processes follow a large-group model |
| - | Among the most expensive options on this list; small startups often find the minimum budget too high |
| - | Best at invention and early development; routine sustaining engineering is not where it adds most value |
Who should choose Velentium?
A typical fit: building a neurostimulator and its clinician programmer.
Combines active-implantable engineering with a dedicated device cybersecurity team that prepares FDA premarket security documentation. Minimum engagement is not publicly disclosed. Works best with clients in Implantables & neuromodulation, Surgical & therapeutic devices, Wearables & remote monitoring.
Who should choose Cambridge Consultants?
A typical fit: feasibility of a new sensing method for a point-of-care diagnostic.
Physicists, chemists and engineers working in one building on problems no off-the-shelf design can solve. Minimum engagement is not publicly disclosed. Works best with clients in Diagnostics & lab devices, Surgical & robotics, Drug delivery, Digital health.
Decision matrix: Velentium vs Cambridge Consultants
| Your situation | Recommended choice |
|---|---|
| You need full-ownership delivery on a defined project scope | Velentium |
| You need a large dedicated team for an ongoing programme | Check each company's engagement model |
| Your budget is at the lower end | Compare: Velentium (Not disclosed) vs Cambridge Consultants (Not disclosed) |
| You need specialist depth in a specific vertical | Cambridge Consultants |
| You need staff augmentation or team extension | Neither; consider alternatives that offer staff aug |
| You need consulting before committing to a build | Both may offer discovery engagements |
Use case fit: Velentium vs Cambridge Consultants
| Use case | Velentium fit | Cambridge Consultants fit | Winner |
|---|---|---|---|
| Building a neurostimulator and its clinician programmer | Strong | Limited | Velentium |
| Preparing the cybersecurity section of an FDA 510(k) or PMA | Strong | Limited | Velentium |
| Feasibility of a new sensing method for a point-of-care diagnostic | Limited | Strong | Cambridge Consultants |
| Early-stage surgical robotics architecture | Limited | Strong | Cambridge Consultants |
Verdict: Velentium vs Cambridge Consultants
Velentium (4.5/5) is the stronger overall choice for most Medical Device Development projects. Combines active-implantable engineering with a dedicated device cybersecurity team that prepares FDA premarket security documentation.
Cambridge Consultants (4.4/5) is worth a look if you need early-stage surgical robotics architecture. If your situation matches that, Cambridge Consultants is a competitive option.
Related comparisons
Velentium vs Cambridge Consultants FAQ
Is Velentium better than Cambridge Consultants?
Velentium (4.5/5) scores higher overall, but "better" depends on your use case. Velentium's strongest advantage: cybersecurity is a full practice here, covering threat modeling, SBOMs, testing and postmarket monitoring. Cambridge Consultants's strongest advantage: rare breadth of science and engineering disciplines for early, risky technology work.
How do Velentium and Cambridge Consultants differ in pricing?
Velentium uses fixed project, time and materials, manufacturing contract pricing. Cambridge Consultants uses time and materials, phased fixed project pricing. Neither firm publishes a full rate card; a discovery call is required for project-specific quotes.
Which is better for enterprise: Velentium or Cambridge Consultants?
Velentium is the larger team and typically the better enterprise-scale choice. For very large programmes, verify team size and compliance coverage directly with each company before shortlisting.
What are the main differences between Velentium and Cambridge Consultants?
Velentium's primary differentiator is: combines active-implantable engineering with a dedicated device cybersecurity team that prepares FDA premarket security documentation. Cambridge Consultants's primary differentiator is: Physicists, chemists and engineers working in one building on problems no off-the-shelf design can solve. They also differ in team size (51–250 vs 900+), minimum engagement (Not disclosed vs Not disclosed), and primary industries served (Implantables & neuromodulation, Surgical & therapeutic devices vs Diagnostics & lab devices, Surgical & robotics).
Verify all details directly with each company before making a decision.